Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04523480 · ClinicalTrials.gov registry record · Phase 3
Testopel ® vs. Generic Testosterone Pellets.
A Phase 3 study of Hypogonadism, sponsored by University of Miami.
- Completed
- Registry status
- Phase 3
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT04523480 is a Phase 3 study of Hypogonadism that has completed, run by University of Miami. The registered enrollment target is 75 participants, below the 117-participant average among 21 other Hypogonadism trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04523480, a Phase 3 study of Hypogonadism, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate changes in vascular parameters in subjects receiving Testopel 75mg (one time) versus subjects receiving Compounded Testosterone pellets 100mg (one time) versus subjects receiving Compounded Testosterone pellets 200mg (one time) to participant with clinical hypogonadism.
Conditions Studied
Interventions
- DRUG Testopel 75mg Drug Implant
- DRUG Testopel 100mg Drug Implant
- DRUG Testopel 200mg Drug Implant
Study Locations (1)
Florida
- University of Miami, Department of Urology - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2020-03-12 |
| Est. Completion | 2022-12-20 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04523480
The ClinicalTrials.gov registry entry for NCT04523480 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 117-participant average among 21 other Hypogonadism trials with a reported enrollment target (36% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypogonadism appearing as the primary indexed condition, and to 3 interventions - of which Testopel 75mg Drug Implant is the first listed.
NCT04523480 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04523480 about?
NCT04523480 is a clinical study titled "Testopel ® vs. Generic Testosterone Pellets.". The purpose of this study is to evaluate changes in vascular parameters in subjects receiving Testopel 75mg (one time) versus subjects receiving Compounded Testosterone pellets 100mg (one time) versus subjects receiving Compounded Testosterone pellets 200mg (one time) to participant with clinical hy...
What is the current status of trial NCT04523480?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 75 participants. The study started on 2020-03-12. Estimated completion is 2022-12-20.
What conditions does trial NCT04523480 study?
This clinical trial studies the following conditions: Hypogonadism.
What interventions are being tested in trial NCT04523480?
The interventions under investigation include: Testopel 75mg Drug Implant (DRUG), Testopel 100mg Drug Implant (DRUG), Testopel 200mg Drug Implant (DRUG).
Who is sponsoring clinical trial NCT04523480?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04523480 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypogonadism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Observation of Environment and Reproductive-Endocrine Effects
RECRUITING
-
Adaptions and Resiliency to Multi-Stressor OpeRations
RECRUITING · Phase 4
-
Inherited Reproductive Disorders
RECRUITING
-
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
RECRUITING · Phase 2
-
The Effect of Sex Steroid Replacement Therapy in the Hypogonadism and Transgender Active-Duty Population
RECRUITING
-
A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.